Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: NovoSeven
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
NovoSeven 120,000unit inj vials
0211000Z0BBABAB
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 1mg (50,000units) inj pfs
0211000Z0BBAHAH
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 1mg (50,000units) inj vials
0211000Z0BBADAD
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 240,000unit inj vials
0211000Z0BBACAC
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 2mg (100,000units) inj pfs
0211000Z0BBAIAI
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 2mg (100,000units) inj vials
0211000Z0BBAEAE
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 5mg (250,000units) inj pfs
0211000Z0BBAJAJ
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 5mg (250,000units) inj vials
0211000Z0BBAFAF
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 60,000unit inj vials
0211000Z0BBAAAA
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 8mg (400,000units) inj pfs
0211000Z0BBAKAK
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 8mg (400,000units) inj vials
0211000Z0BBAGAG
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.